286 related articles for article (PubMed ID: 29847471)
21. Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.
Gomez K; Allen HN; Duran P; Loya-Lopez S; Calderon-Rivera A; Moutal A; Tang C; Nelson TS; Perez-Miller S; Khanna R
Pain; 2024 Apr; 165(4):866-883. PubMed ID: 37862053
[TBL] [Abstract][Full Text] [Related]
22. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
Xie JY; Chew LA; Yang X; Wang Y; Qu C; Wang Y; Federici LM; Fitz SD; Ripsch MS; Due MR; Moutal A; Khanna M; White FA; Vanderah TW; Johnson PL; Porreca F; Khanna R
Pain; 2016 Sep; 157(9):2124-2140. PubMed ID: 27537210
[TBL] [Abstract][Full Text] [Related]
23. Selective targeting of NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents.
Cai S; Moutal A; Yu J; Chew LA; Isensee J; Chawla R; Gomez K; Luo S; Zhou Y; Chefdeville A; Madura C; Perez-Miller S; Bellampalli SS; Dorame A; Scott DD; François-Moutal L; Shan Z; Woodward T; Gokhale V; Hohmann AG; Vanderah TW; Patek M; Khanna M; Hucho T; Khanna R
Sci Transl Med; 2021 Nov; 13(619):eabh1314. PubMed ID: 34757807
[TBL] [Abstract][Full Text] [Related]
24. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
[TBL] [Abstract][Full Text] [Related]
25. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-30b regulates expression of the sodium channel Nav1.7 in nerve injury-induced neuropathic pain in the rat.
Shao J; Cao J; Wang J; Ren X; Su S; Li M; Li Z; Zhao Q; Zang W
Mol Pain; 2016; 12():. PubMed ID: 27765894
[TBL] [Abstract][Full Text] [Related]
27. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
[TBL] [Abstract][Full Text] [Related]
28. Mapping protein interactions of sodium channel Na
Kanellopoulos AH; Koenig J; Huang H; Pyrski M; Millet Q; Lolignier S; Morohashi T; Gossage SJ; Jay M; Linley JE; Baskozos G; Kessler BM; Cox JJ; Dolphin AC; Zufall F; Wood JN; Zhao J
EMBO J; 2018 Feb; 37(3):427-445. PubMed ID: 29335280
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury.
Moutal A; Ji Y; Bellampalli SS; Khanna R
Mol Brain; 2020 Jun; 13(1):97. PubMed ID: 32571373
[TBL] [Abstract][Full Text] [Related]
30. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
31. Conditional knockout of CRMP2 in neurons, but not astrocytes, disrupts spinal nociceptive neurotransmission to control the initiation and maintenance of chronic neuropathic pain.
Boinon L; Yu J; Madura CL; Chefdeville A; Feinstein DL; Moutal A; Khanna R
Pain; 2022 Feb; 163(2):e368-e381. PubMed ID: 35029600
[TBL] [Abstract][Full Text] [Related]
32. Intranasal CRMP2-Ubc9 Inhibitor Regulates Na
Loya-Lopez SI; Allen HN; Duran P; Calderon-Rivera A; Gomez K; Kumar U; Shields R; Zeng R; Dwivedi A; Saurabh S; Korczeniewska OA; Khanna R
bioRxiv; 2023 Jul; ():. PubMed ID: 37502910
[TBL] [Abstract][Full Text] [Related]
33. Activation of tetrodotoxin-resistant sodium channel NaV1.9 in rat primary sensory neurons contributes to melittin-induced pain behavior.
Yu YQ; Zhao ZY; Chen XF; Xie F; Yang Y; Chen J
Neuromolecular Med; 2013 Mar; 15(1):209-17. PubMed ID: 23264124
[TBL] [Abstract][Full Text] [Related]
34. Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.
Bang S; Yoo J; Gong X; Liu D; Han Q; Luo X; Chang W; Chen G; Im ST; Kim YH; Strong JA; Zhang MZ; Zhang JM; Lee SY; Ji RR
Neurosci Bull; 2018 Feb; 34(1):22-41. PubMed ID: 29333591
[TBL] [Abstract][Full Text] [Related]
35. TNF-α contributes to up-regulation of Nav1.3 and Nav1.8 in DRG neurons following motor fiber injury.
He XH; Zang Y; Chen X; Pang RP; Xu JT; Zhou X; Wei XH; Li YY; Xin WJ; Qin ZH; Liu XG
Pain; 2010 Nov; 151(2):266-279. PubMed ID: 20638792
[TBL] [Abstract][Full Text] [Related]
36. A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain.
Hildebrand ME; Smith PL; Bladen C; Eduljee C; Xie JY; Chen L; Fee-Maki M; Doering CJ; Mezeyova J; Zhu Y; Belardetti F; Pajouhesh H; Parker D; Arneric SP; Parmar M; Porreca F; Tringham E; Zamponi GW; Snutch TP
Pain; 2011 Apr; 152(4):833-843. PubMed ID: 21349638
[TBL] [Abstract][Full Text] [Related]
37. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
38. Collapsin response mediator protein 2 (CRMP2) interacts with N-methyl-D-aspartate (NMDA) receptor and Na+/Ca2+ exchanger and regulates their functional activity.
Brustovetsky T; Pellman JJ; Yang XF; Khanna R; Brustovetsky N
J Biol Chem; 2014 Mar; 289(11):7470-82. PubMed ID: 24474686
[TBL] [Abstract][Full Text] [Related]
39. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.
Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R
Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890
[TBL] [Abstract][Full Text] [Related]
40. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
Feldman P; Khanna R
Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
